Clinical Trials in Bozhou, Anhui
7 recruiting
Showing 1–7 of 7 trials
Recruiting
Phase 4
The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients
Acute Coronary SyndromeHelicobacter Pylori Infection
Qilu Hospital of Shandong University2,600 enrolled42 locationsNCT04728516
Recruiting
China Liver Cancer Clinical Registry Cohort Database (HEAL)
Liver Cancer
Anhui Provincial Hospital10,000 enrolled38 locationsNCT06777485
Recruiting
Phase 3
TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection
Asthma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.660 enrolled74 locationsNCT06829784
Recruiting
Phase 4
China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)
HypertensionMTHFR 677 CC or CT GenotypeElevated Plasma Homocysteine (Hcy≥10µmol/L)+1 more
Shenzhen Ausa Pharmed Co.,Ltd32,000 enrolled20 locationsNCT04974138
Recruiting
Phase 4
China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype
HypertensionMTHFR 677 TT Genotype
Shenzhen Ausa Pharmed Co.,Ltd24,000 enrolled20 locationsNCT04974151
Recruiting
Phase 2
The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.42 enrolled16 locationsNCT06452706
Recruiting
Phase 3
A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis
Lupus Nephritis
Qilu Pharmaceutical Co., Ltd.270 enrolled10 locationsNCT06406205